Rubric Capital Management (New York)’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $45.2M | Buy |
|
|||||
|
2025
Q2 | $22.6M | Buy |
|
|||||
|
2025
Q1 | $12.9M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $5.44M | Hold |
|
|||||
|
2024
Q1 | $6.53M | Hold |
|
|||||
|
2023
Q4 | $3.5M | Hold |
|
|||||
|
2023
Q3 | $2.42M | Sell |
|
|||||
|
2023
Q2 | $18.8M | Sell |
|
|||||
|
2023
Q1 | $22.7M | Buy |
|
|||||
|
2022
Q4 | $25.5M | Buy |
|
|||||
|
2022
Q3 | $14.2M | Buy |
|
|||||
|
2022
Q2 | $4.18M | Buy |
|